Home » Stocks » Histogen

Histogen, Inc. (HSTO)

Stock Price: $2.90 USD 0.16 (5.84%)
Updated Aug 10, 2020 4:00 PM EDT - Market closed
After-hours: $2.91 +0.01 (0.35%) Aug 10, 5:34 PM

Stock Price Chart

Key Info

Market Cap 34.26M
Revenue (ttm) 4.28M
Net Income (ttm) -10.12M
Shares Out 12.21M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $2.90
Previous Close $2.74
Change ($) 0.16
Change (%) 5.84%
Day's Open 2.65
Day's Range 2.63 - 3.59
Day's Volume 58,881
52-Week Range 2.30 - 7.50

More Stats

Market Cap 34.26M
Enterprise Value 16.44M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 12.21M
Float 8.02M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -4.79
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 15,803
Short Ratio 1.50
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.01
PB Ratio 1.94
Revenue 4.28M
Operating Income -10.66M
Net Income -10.12M
Free Cash Flow -15.89M
Net Cash 17.82M
Net Cash / Share 1.51
Gross Margin 71.51%
Operating Margin -249.06%
Profit Margin -68.90%
FCF Margin -371.53%
ROA -53.94%
ROE -210.97%
ROIC -268.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $2.90
Target: 15.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-35.34%-5.06%4327.66%------
Gross Profit21.7233.5935.380.80-----
Operating Income-12.01-18.28-17.55-29.83-24.13-22.29-11.60-8.61-12.36
Net Income-11.39-18.01-17.40-29.73-24.15-22.32-15.62-8.75-12.00
Shares Outstanding3.323.042.862.271.861.550.740.100.10
Earnings Per Share-3.40-5.90-6.10-13.10-13.00-14.40-6.30-86.00-118.60
Operating Cash Flow-20.20-34.86-33.2127.00-22.55-18.26-10.63-8.56-12.10
Capital Expenditures-0.01-0.07-0.03-0.11-0.09-0.24--0.02-0.02
Free Cash Flow-20.21-34.92-33.2326.89-22.63-18.50-10.64-8.58-12.11
Cash & Equivalents20.7040.6974.8577.0236.5137.0756.358.0316.76
Total Debt0.34-
Net Cash / Debt20.3740.6961.7076.0235.5136.0755.357.0315.76
Book Value20.1927.4028.0021.7934.5433.2153.12-58.34-49.74
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Histogen, Inc.
Country United States
Employees 22
CEO Richard W. Pascoe

Stock Information

Ticker Symbol HSTO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: HSTO


Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.